Breast cancer is the most commonly diagnosed cancer among American women. Many of these women – an estimated 75% – were prescribed the injectable concentrate Taxotere as part of their chemotherapy treatment. A 2013 study published by the National Cancer Research Institute found permanent alopecia to occur in 10-15% of patients who took Taxotere.
Permanent alopecia is defined as absent or incomplete hair growth at least 6 months after chemotherapy. There is no antidote for this medication, which means many women prescribed this drug will never get their hair back.
Taxotere is currently being investigated by the FDA for its failure to warn patients about this disheartening side effect.
If you’re one of the thousands of women who have been adversely affected by Taxotere, we want to help you seek compensation for your permanent hair loss.
The attorneys of Childers, Schlueter & Smith have successfully litigated against defective drugs that harm patients across the country. We believe women who have survived the fight of their lives deserve to be compensated for a side effect they probably were not aware of. If you are one of the many women affected by Taxotere, please contact us today for a 100% free case evaluation.
Taxotere Side Effects Study
Annals of Oncology published one of the first studies uncovering Taxotere’s permanent hair loss side effects in May of 2012. Only 2 out of 24 patients had their hair return normally after Taxotere chemotherapy treatment. Taxotere destroys the hair follicle and no regrowth treatments – vitamin supplements, topical minoxidil (Rogaine) or psolare and ultraviolet treatments – have been found to restore hair growth.
Could Your Hair Loss Have Been Avoided?
When a patient is diagnosed with cancer, the doctor’s top priority is saving a patient’s life, if possible. Hair regrowth is not of major concern because a patient’s hair typically grows back 3-6 months after chemotherapy.
As cancer treatments go, Taxotere was hailed by many doctors as a “wonder drug” for its ability to effectively reduce tumor growth in patients. However, other drugs on the market are just as effective and do not carry the risk of permanent hair loss.
In December 2015, the FDA required Taxotere drug makers to include a label safety warning for its permanent alopecia side effect. Chemotherapy treatment is not easy on the body, and many drugs carry side effects. However, only Taxotere has been found to cause permanent hair loss 6 months after chemotherapy treatments ends and cancer is in remission.
Contact our Defective Drug Law Firm
If you or a loved one is living with permanent alopecia after taking Taxotere, our firm would like to help you heal. We know nothing can restore your hair, but we may help improve the quality of your life and your sense of justice. Consumers deserve to know all the risks that come with taking a pharmaceutical drug, regardless of its benefits.
The defective drug attorneys at Childers, Schlueter & Smith are currently reviewing Taxotere cases for women who have permanent hair loss. If you have questions or concerns, please contact us today for your free case evaluation. All inquiries are completely confidential and at no obligation to you.